uniQure (QURE) Deferred Taxes (2016 - 2026)
uniQure (QURE) recorded quarterly Deferred Taxes of $500000.0 in Q1 2026, little changed quarter-over-quarter from $500000.0 in Q2 2025, and little changed on a YoY basis from $500000.0 in Q1 2025.
uniQure (QURE) Deferred Taxes (2016 - 2026) Analysis & Trends
uniQure's Deferred Taxes history runs 9 years deep, the most recent figure standing at $500000.0 for Q1 2026.
- In Q1 2026, Deferred Taxes changed 0.0% year-over-year to $500000.0; the TTM figure through Mar 2026 stood at $1.5 million (down 28.57% YoY), while the FY2021 annual figure was $3.2 million, up 119.55% from the prior year.
- Deferred Taxes was $500000.0 for Q1 2026 at uniQure, roughly flat from $500000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $1.2 million in Q1 2023 to a low of -$616000.0 in Q1 2022.
- Historically, Deferred Taxes has averaged $416727.3 across 5 years, with a median of $500000.0 in 2025.
- The sharpest annual moves came in 2022 and 2024: Deferred Taxes tumbled 389.2% in 2022, then surged 350.0% in 2024.
- A 5-year view of Deferred Taxes shows it stood at $300000.0 in 2022, then tumbled by 66.67% to $100000.0 in 2023, then soared by 800.0% to $900000.0 in 2024, then slumped by 44.44% to $500000.0 in 2025, then changed by 0.0% to $500000.0 in 2026.
- The last three Deferred Taxes figures came in at $500000.0 (Q1 2026), $500000.0 (Q2 2025), and $500000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 500,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Mar 31, 2025 | 500,000.00 |
| Jun 30, 2024 | 900,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 1.20 Mn |
| Sep 30, 2022 | 300,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | -616,000.00 |
| Dec 31, 2021 | -350,000.00 |
| Jun 30, 2021 | 3.30 Mn |
| Mar 31, 2021 | 213,000.00 |
| Dec 31, 2020 | -16.42 Mn |
| Dec 31, 2018 | -6,000.00 |
| Sep 30, 2018 | -32,000.00 |
| Jun 30, 2018 | 361,000.00 |
| Mar 31, 2018 | -92,000.00 |
| Dec 31, 2016 | 744,000.00 |